"Is CBD a drug?" This is probably the question we're asked the most, right after "does it get you high?". Behind it lies a real concern: fear of breaking the law, becoming addicted, or risking one's health. The short answer: no, CBD is neither a drug in the common sense, nor a narcotic in the legal sense. Here's why, point by point — and especially where the real trap lies.
Key takeaways
- CBD is non-psychoactive: it does not get you high and does not alter consciousness, unlike THC.
- As early as 2017, the WHO concluded that pure CBD does not have abuse potential or pose a risk to public health.
- In France, CBD is legal with less than 0.3% THC and is not a narcotic — unlike synthetic cannabinoids (HHC, H4CBD) which have been classified as narcotics since 2024.
Is CBD a drug?
No. CBD (cannabidiol) is a non-psychoactive molecule: it does not cause euphoria, a "high," or altered perception. In 2017, the World Health Organization stated in its pre-review report that cannabidiol does not produce euphoric effects and has no abuse potential. Where the word "drug" evokes a product that alters consciousness and creates dependence, CBD checks neither of these boxes.
This is the whole misunderstanding: CBD comes from the same plant as recreational cannabis, but it is not the same molecule. The component that gets you high is THC — not CBD. CBD is consumed for a relaxing effect, not for an intoxicating effect. The nuance changes everything, legally as well as physiologically.
Is CBD a narcotic in the eyes of the law?
No, not in France in 2026. Cannabidiol is not listed as a narcotic. The framework is clear: the decree of December 30, 2021, authorizes hemp and its products on the condition that the finished product contains less than 0.3% THC. The decision of the Council of State on December 29, 2022, confirmed the legality of selling CBD flowers and leaves.
In other words, what is regulated is THC, not CBD. A compliant flower or oil remains below the legal threshold and does not fall under the narcotics law. For full details of the French legal framework, we have written a dedicated guide: the CBD law in France in 2026.
CBD, THC, and "soft drug": what are the differences?
The difference lies in one word: psychoactivity. THC is psychoactive and classified as a narcotic; CBD is not. The term "soft drug" generally refers to THC-rich cannabis with a moderate effect — a category that CBD does not fall into, precisely because it does not get you high.
Specifically, the two molecules act differently on the body:
- THC binds strongly to CB1 receptors in the brain: this is what causes the high and classifies it as a narcotic.
- CBD interacts with the endocannabinoid system indirectly, without euphoric effect. We speak of relaxation, not intoxication.
Calling CBD a "soft drug" is therefore inaccurate. It is not a milder version of recreational cannabis: it is a different molecule, without the problematic component.
Is CBD addictive?
No, according to available data. In its 2017 report, and then its 2018 critical review, the WHO concluded that CBD does not have abuse potential or create dependence in humans. No withdrawal syndrome comparable to that of tobacco or THC has been described for cannabidiol alone.
This is even one of the reasons why some former consumers use it as support to reduce THC or tobacco: they keep the ritual without the addictive molecule. CBD does not create the cycle of addiction — which does not mean that it should be consumed without thought, as with any product.
Is CBD dangerous for health?
CBD is generally well tolerated: the WHO described a "good safety profile" in 2018. Reported side effects remain mild and infrequent — fatigue, dry mouth, sometimes digestive issues or low blood pressure. Important clarification: CBD is not a medicine and does not cure any disease. We are talking about a wellness product, not a treatment.
A few points of vigilance, to be honestly aware of:
- High doses: studies on pharmaceutical CBD (at very high doses, unrelated to wellness use) have observed elevations in liver enzymes. At common doses, this is not the same context, but it suggests not overconsuming.
- Drug interactions: CBD can interfere with how the liver metabolizes certain medications. If you are on medication, ask your doctor or pharmacist for advice before taking it.
- Pregnancy and breastfeeding: as a precaution, CBD is not recommended. When in doubt, abstain.
- Method of consumption: combustion (smoking) produces irritating compounds regardless of the material burned. Vaporization or infusion better preserves the flower.
In short: no established danger for a healthy adult at reasonable doses, but common sense and medical advice in case of treatment.
False "drugs" sold as CBD
This is the real trap, and our red line. The danger does not come from CBD, but from synthetic molecules sold under misleading names: HHC, H4CBD, HHCPO, THCP, "CBD+". These are semi-synthetic cannabinoids, classified as narcotics in France since June 2024 (ANSM). Unlike CBD, they are psychoactive and their safety profile remains poorly understood.
In 2025, the ANSM even warned about hundreds of intoxications linked to products labeled CBD but containing these undeclared molecules. The rule is simple: a genuine CBD seller does not market any of these derivatives. We do not sell them, by sanitary choice. To understand each molecule and its risks, read our guide on hemp derivatives (HHC, H4CBD, HHCPO). When searching "synthetic CBD drug," this is precisely what to watch out for.
CBD and drug tests: is there a risk of a positive result?
Roadside saliva tests detect THC, not CBD. Consuming pure CBD therefore does not result in a positive test. The real risk comes from a poorly traced product: a flower or oil exceeding 0.3% THC can be enough to trigger a positive test.
This highlights the importance of the certificate of analysis: it proves the compliance of the THC level. If you're driving, prioritize products for which analysis is available. We detail the rules in our dedicated article: can you drive after consuming CBD?
In summary
CBD is not a drug: it is non-psychoactive, does not cause dependence (WHO 2017), and remains legal in France with less than 0.3% THC. It is not a "soft drug," nor a narcotic. The real risk lies in synthetic cannabinoids disguised as CBD — which are indeed classified as narcotics. The solution: buy compliant, traceable, and without synthetics. You can browse our compliant CBD flowers, all with less than 0.3% THC and with analyses.
Frequently Asked Questions
Is CBD a narcotic?
No. Cannabidiol is not listed as a narcotic in France. Only THC is. A compliant CBD product contains less than 0.3% THC (decree of December 30, 2021), which places it outside the scope of the narcotics law.
Is CBD a soft drug?
No. A "soft drug" refers to cannabis with a moderate psychoactive effect. CBD does not get you high and does not alter consciousness: it does not fall into this category. It is a distinct molecule from THC, without intoxicating effect.
Is CBD addictive?
No, according to the WHO (2017-2018): CBD does not have abuse potential or create dependence, and no withdrawal syndrome has been described. This is different from nicotine or THC, which do cause dependence.
Can CBD cause a positive saliva test?
Pure CBD, no: tests detect THC. The risk comes from a non-compliant product containing more than 0.3% THC. An up-to-date certificate of analysis is the best guarantee before driving.
I have a concern about consumption, where can I find help?
For any questions about drugs, alcohol, or tobacco, Drogues Info Service offers anonymous and free support at 0 800 23 13 13 (7 days a week) and on drogues-info-service.fr. For tobacco cessation, Tabac Info Service at 3989.
Sources
- World Health Organization (WHO), "Cannabidiol (CBD) — Critical Review Report," Expert Committee on Drug Dependence, 2018. who.int, accessed 2026-06-24.
- Decree of December 30, 2021, relating to hemp (0.3% THC threshold). Légifrance, accessed 2026-06-24.
- Council of State, decision of December 29, 2022 (legality of CBD flowers and leaves). conseil-etat.fr, accessed 2026-06-24.
- ANSM — classification of HHC and its derivatives as narcotics (2024) and warning about synthetic cannabinoid intoxications (2025). ANSM, accessed 2026-06-24.
- MILDECA — CBD. drogues.gouv.fr, accessed 2026-06-24.